Accel Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$206K Buy
3,580
+11
+0.3% +$632 0.05% 287
2026
Q1
$216K Buy
+3,569
New +$208K 0.06% 262
2025
Q2
Sell
-4,603
Closed -$281K 271
2025
Q1
$281K Sell
4,603
-71
-2% -$4.14K 0.1% 195
2024
Q4
$264K Buy
4,674
+271
+6% +$15.1K 0.1% 199
2024
Q3
$228K Sell
4,403
-436
-9% -$20.5K 0.08% 218
2024
Q2
$201K Sell
4,839
-95
-2% -$4.25K 0.08% 227
2024
Q1
$268K Buy
4,934
+788
+19% +$40.1K 0.11% 168
2023
Q4
$213K Buy
4,146
+467
+13% +$24.5K 0.11% 177
2023
Q3
$214K Buy
+3,679
New +$225K 0.12% 155
2023
Q2
Sell
-2,996
Closed -$208K 248
2023
Q1
$208K Buy
2,996
+40
+1% +$2.82K 0.08% 212
2022
Q4
$213K Buy
2,956
+190
+7% +$14.3K 0.1% 154
2022
Q3
$197K Buy
2,766
+9
+0.3% +$653 0.11% 160
2022
Q2
$209K Buy
2,757
+9
+0.3% +$685 0.12% 141
2022
Q1
$203K Buy
2,748
+335
+14% +$22.5K 0.1% 151
2021
Q4
$150K Buy
2,413
+119
+5% +$6.98K 0.07% 200
2021
Q3
$136K Buy
2,294
+575
+33% +$37.9K 0.09% 180
2021
Q2
$115K Sell
1,719
-337
-16% -$22K 0.08% 213
2021
Q1
$130K Sell
2,056
-397
-16% -$24.7K 0.11% 180
2020
Q4
$152K Buy
+2,453
New +$151K 0.14% 151

Other funds holding BMY

Accel Wealth Management's BMY Position: Q2 2026 in Review

Accel Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.31% in Q2 2026, buying an estimated $632 and bringing the position to 3,580 shares worth $206K. The position accounts for 0.05% of the portfolio, ranked #287.

Accel Wealth Management first reported a position in BMY in Q4 2020 and has held it in 19 quarters since. The position peaked at $281K in Q1 2025. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Accel Wealth Management held 3,580 shares of Bristol-Myers Squibb worth $206K as of Q2 2026.
  • Accel Wealth Management bought 11 Bristol-Myers Squibb shares in Q2 2026, an estimated $632.
  • Bristol-Myers Squibb made up 0.05% of Accel Wealth Management's portfolio in Q2 2026, its #287 holding.
  • Accel Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 19 quarters since.
  • Accel Wealth Management's Bristol-Myers Squibb position peaked at $281K in Q1 2025.
  • 1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.